Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn Phillips

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
BMC Psychiatry|December 30, 2011
The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trialLei Chen, Glenn Phillips, Joseph Johnston, et al.
Neurology|January 2, 2024
Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National DatasetsAli A Habib, Naomi Sacks, Christina Cool, et al.
Journal of Comparative Effectiveness Research|May 8, 2026
Evaluation of steroid toxicity using the Glucocorticoid Toxicity Index-Metabolic Domains instrument in adults with myasthenia gravis: a real-world study in the USAGlenn Phillips, Cynthia Qi, Deborah Gelinas, et al.
The Journal of Clinical Psychiatry|February 8, 2011
Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy changeJames Signorovitch, Howard Birnbaum, Rym Ben-Hamadi, et al.
Journal of the Neurological Sciences|April 29, 2022
The humanistic burden of myasthenia gravis: A systematic literature reviewDeborah Gelinas, Sara Parvin-Nejad, Glenn Phillips, et al.
Journal of the Neurological Sciences|November 8, 2022
Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United StatesCynthia Z Qi, Tom Hughes, Deborah Gelinas, et al.
Frontiers in Public Health|September 28, 2023
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challengesTom Hughes, James F Howard, Nicholas J Silvestri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosisLaura J Balcer, Jenelle Raynowska, Rachel Nolan, et al.
Muscle & Nerve|May 5, 2023
Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scoresSarah Dewilde, M F Janssen, Nafthali H Tollenaar, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2020
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple SclerosisLouis S Matza, Glenn Phillips, Barry Dewitt, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
BMC Psychiatry|December 30, 2011
The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trialLei Chen, Glenn Phillips, Joseph Johnston, et al.
Neurology|January 2, 2024
Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National DatasetsAli A Habib, Naomi Sacks, Christina Cool, et al.
Journal of Comparative Effectiveness Research|May 8, 2026
Evaluation of steroid toxicity using the Glucocorticoid Toxicity Index-Metabolic Domains instrument in adults with myasthenia gravis: a real-world study in the USAGlenn Phillips, Cynthia Qi, Deborah Gelinas, et al.
The Journal of Clinical Psychiatry|February 8, 2011
Increased olanzapine discontinuation and health care resource utilization following a Medicaid policy changeJames Signorovitch, Howard Birnbaum, Rym Ben-Hamadi, et al.
Journal of the Neurological Sciences|April 29, 2022
The humanistic burden of myasthenia gravis: A systematic literature reviewDeborah Gelinas, Sara Parvin-Nejad, Glenn Phillips, et al.
Journal of the Neurological Sciences|November 8, 2022
Real-world utilization patterns of intravenous immunoglobulin in adults with generalized myasthenia gravis in the United StatesCynthia Z Qi, Tom Hughes, Deborah Gelinas, et al.
Frontiers in Public Health|September 28, 2023
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challengesTom Hughes, James F Howard, Nicholas J Silvestri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2017
Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosisLaura J Balcer, Jenelle Raynowska, Rachel Nolan, et al.
Muscle & Nerve|May 5, 2023
Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) scoresSarah Dewilde, M F Janssen, Nafthali H Tollenaar, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2020
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple SclerosisLouis S Matza, Glenn Phillips, Barry Dewitt, et al.
Pageof 5